Jiangsu CK Rehab Co., Ltd (CK Rehab) is a national high-tech enterprise established in 2015. CK Rehab has been committed to the development and production of professional rehabilitation therapy equipment. Our products are widely used in domestic and foreign various levels of rehabilitation therapy markets. The leaders of our company are all senior medical professionals. Especially after Mr. Dong Ruiping (Postdoctor from Harvard Medical School) joined the company in 2020, it makes CK Rehab entered a period of rapid development.

CK Rehab has own high-end air compression therapy brand "Flybear" which includes four major series and more than 20 models, including air compression therapy system, intermittent pulse pressure prevent thrombotic system (DVT), air compression massage system, and leg recovery system. Our products applied to many areas such as hospitals, elderly care centers, community centers, clinics, families and sports. CK Rehab always adheres to the development concept of pursuing innovation and win-win cooperation, adheres to the spirit of craftsmanship, and committed to becoming a leader in the air compression therapy system industry. Currently, the rehabilitation physiotherapy products with core technologies of CK Rehab developed on the basis of high-end talents in the medical and R&D that are leading domestically. Some performance indicators have even surpassed those of similar international products.  Simultaneously, CK Rehab has emerged as a large-scale and specialized enterprise integrating production and research in the field of air compression therapy system on the global stage.

After years of development, CK Rehab has become the leader in the domestic air compression therapy system industry, especially the products for household using owns a high marketing share. Since the end of 2023, CK Rehab entered the international market and carried out substantial cooperation with some partners in  USA, Europe and Asia.  And CK Rehab won the favor of many customers with our high-quality products and services, as well as ultra-high cost performance.  We will continue to meet customer needs as our responsibility, not limited to agency model, OEM, ODM and other cooperation models. We will work with our partners to promote the development of the health field.